Delivery Order SPE2DB22D9205-SPE2DB24FZG55

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,678.70 contract is for the delivery of NUCALA 100 MG/ML auto-injector medication and has an ultimate completion date of April 26, 2024. This delivery order is placed under a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,464.50 order is for NUCALA 100 MG/ML auto-injector medication and has a completion date of May 24, 2024. DMS Pharmaceutical Group holds a large indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that runs through December 31, 2025. This single-award vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract with a ceiling value of $18,929.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order was placed under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The current delivery order is for the supply of 4565047756 - NUCALA 100...
The Defense Logistics Agency (DLA) awarded a $7,571.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the supply of Nucala 100 mg/mL auto-injector medication and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,678.70 firm fixed-price contract is for the delivery of NUCALA 100 MG/ML AUTO-INJECTORML, with a period of performance through May 7, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to provide a comprehensive range...
This is a $5,678.70 firm fixed-price delivery order awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4,564,895,276 units of the drug NUCALA 100 MG/ML AUTO-INJECTORML and has a completion date of June 13, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order for $5,678.70 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Nucala 100 mg/mL auto-injector medication and has an ultimate completion date of January 28, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,571.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group, is for the supply of Nucala 100 mg/mL auto-injectors to support the recurring medical supply needs of military health facilities worldwide. DMS...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order was issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The current delivery order is for the supply of NUCALA 100 MG/ML...
The U.S. government agency, the Defense Logistics Agency (DLA), has awarded a firm fixed-price delivery order contract worth $7,571.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of NUCALA 100 MG/ML AUTO-INJECTORML and has a period of performance through May 3, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
  • SPE2DB22D9205
    Indefinite Delivery Contract
  • SPE2DB22D9205-SPE2DB24FZG55
    Delivery Order

This firm fixed-price delivery order for $5,678.70 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of NUCALA 100 MG/ML AUTO-INJECTOR medication and has an ultimate completion date of August 9, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide array of branded and generic medications, biologics, and medical consumables to the Department of Defense (DoD) and Department of Veterans Affairs (VA).

Generated 11/7/24, 9:37 AM